Semaglutide is non-inferior to placebo for cardiovascular outcomes in patients with type 2 diabetesDenise Campbell-Scherer
7 March 2017
Evidence-based medicine: a persisting desire under fireFares Alahdab, Samer Alabed, Ahmed Al-Moujahed, Mohammad Anass Al Sallakh, Tareq Alyousef, Ubai Alsharif, Munes Fares, M Hassan Murad
13 December 2016
Grading the quality of evidence in complex interventions: a guide for evidence-based practitionersM Hassan Murad, Jehad Almasri, Mouaz Alsawas, Wigdan Farah
8 December 2016
Value and usability of unpublished data sources for systematic reviews and network meta-analysesNicholas James Anthony Halfpenny, Joan Mary Quigley, Juliette Catherine Thompson, David Alexander Scott
29 September 2016
‘Spin’ in reports of clinical researchKamal R Mahtani
13 October 2016
Do not throw the baby out with the bath water: a guide for using non-significant results in practiceMouaffaa Tello, Feras Zaiem, Mary Catherine Tolcher, Mohammad Hassan Murad
18 August 2016
Are eponyms used correctly or not? A literature review with a focus on shoulder and elbow surgeryMatthijs Paul Somford, Rebecca A Nieuwe Weme, Cornelis Niek van Dijk, Frank FA IJpma, Denise Eygendaal
26 August 2016
EBHC pyramid 5.0 for accessing preappraised evidence and guidanceBrian S Alper, R Brian Haynes
20 June 2016
Low-density lipoprotein cholesterol goals: still not in patients' best interestMartin Mayer
5 April 2016
Clinicians should think twice before prescribing DPP-4 inhibitors for diabetesJoshua J Fenton
21 April 2016